Mark G. Currie
2013
In 2013, Mark G. Currie earned a total compensation of $1.7M as Senior Vice President, Chief Scientific Officer and President of R&D at Ironwood Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $90,408 |
|---|---|
| Option Awards | $1,228,100 |
| Salary | $376,700 |
| Other | $7,440 |
| Total | $1,702,648 |
Currie received $1.2M in option awards, accounting for 72% of the total pay in 2013.
Currie also received $90.4K in non-equity incentive plan, $376.7K in salary and $7.4K in other compensation.
Rankings
In 2013, Mark G. Currie's compensation ranked 4,457th out of 12,286 executives tracked by ExecPay. In other words, Currie earned more than 63.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,457 out of 12,286 | 64th |
Division Manufacturing | 1,530 out of 4,612 | 67th |
Major group Chemicals And Allied Products | 434 out of 1,462 | 70th |
Industry group Drugs | 299 out of 1,156 | 74th |
Industry Pharmaceutical Preparations | 240 out of 890 | 73rd |
Source: SEC filing on April 15, 2016.
Currie's colleagues
We found three more compensation records of executives who worked with Mark G. Currie at Ironwood Pharmaceuticals in 2013.